Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Eli Lilly, Novo Nordisk
Eli Lilly’s stock plunges as investors eye obesity-drug competition
Eli Lilly & Co.’s stock was on pace for its worst day in about three years Thursday as investors fretted about intensifying competition among obesity-drug developers. Lilly’s stock was down more than 7% at midday Thursday — on track for its largest percentage decline since March 2021 — before rebounding slightly.
Novo Nordisk, Eli Lilly Slip as Roche Weight-Loss Drug Shows Promise
A new non-injectable weight-loss drug from Swiss pharmaceutical firm Roche has shown encouraging early stage data, sending shares of rival GLP-1 developers Eli Lilly and Novo Nordisk lower Wednesday.
Palantir, Netflix, Domino's Pizza, Eli Lilly, Tesla: Why These 5 Stocks Are On Investors' Radars Today
The Dow Jones Industrial Average dropping nearly 1.3% to 40,665.03 on Thursday, the S&P 500 and Nasdaq declined as well.
24/7 Wall St on MSN
10h
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 553% and ...
18h
on MSN
Eli Lilly, Novo extend muti-day decline in rare selloff
Shares of weight loss drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) extended a multi-day decline on Thursday, losing ...
The Motley Fool on MSN
1d
Will Eli Lilly Do a Stock Split in 2024?
The healthcare
company
hasn't done a stock split in decades; its last one was a 2-for-1 back in 1997. While that's ...
3d
This Analyst Sees Potential Downside In Eli Lilly, Adjusts Model For Acquired IPR&D Charges
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on Eli Lilly with a price target of $885. Eli Lilly's ...
24/7 Wall St. on MSN
7d
Will Wall Street Darling Eli Lilly's Stock Split Next?
Eli Lilly (NYSE: LLY) stock has been a winner for investors of late, owing largely to strong consumer demand for obesity ...
10d
on MSN
Eli Lilly Buys Bowel Disease Drug Developer Morphic In $3.2 Billion Deal
Eli Lilly will acquire biopharmaceutical firm Morphic Holding in a deal valued at $3.2 billion, both companies announced ...
Business Insider
18h
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
GLP-1 market leaders
Eli Lilly and Company
(NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) faced a significant selloff on Thursday, as new weight-loss drugs from rival pharmaceutical companies began ...
8d
on MSN
Analyst revamps Eli Lilly stock price target ahead of Q2 earnings
Eli Lilly, with a market value of nearly $900 billion, has vaulted past Tesla into the top 10 list of U.S. companies.
FiercePharma
3d
Eli Lilly vaults Simone Biles to head of Mounjaro ad campaign, partnering with Olympian for TV spot
Lilly is promoting Mounjaro despite facing supply constraints. Anat Ashkenazi, chief financial officer at Lilly, told ...
18h
on MSN
What's Going On With Eli Lilly And Company Shares Thursday?
Eli Lilly and Company (NYSE:LLY) stock is moving lower on Thursday on possible continued weakness after recent weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
New York Stock Exchange
Roche
Novo Nordisk
CT-996
Alzheimer's disease
Feedback